Talogreptide mesaroxetan

DB21743ExperimentalSmall molecule

Talogreptide mesaroxetan is a small molecule drug. The usage of the INN stem '-xetan' in the name indicates that Talogreptide mesaroxetan is a chelating agent. Talogreptide mesaroxetan has a monoisotopic...

Formula / weight: C₈₆H₁₄₀N₂₂O₁₈ · 1770.202 g/mol (avg)
Code names: SAR-BBN free base non-labeled

Resolves to

Compound

UNIIZUN64K4H2XCAS1801418-23-4

Structure

InChIKeySPYWMRXLJVOTHY-RZLLKRBWSA-NSMILES

CC(C)C[C@H](NC(=O)[C@H](CC1=CNC=N1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)CCOCCOCCOCCOCCNC(=O)CCCC(=O)NC12CNCCNCC(C)(CNCCNC1)CNCCNC2)C(C)C)[C@@H](O)CC(=O)N[C@@H](CC(C)C)C(N)=O

Which companies are running trials of Talogreptide mesaroxetan, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account